Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Dosing: Tirzepatide's therapeutic doses (515 mg/week) are significantly higher by mass than semaglutide (0.252.4 mg/week), requiring more active ingredient per vial
For inclusion in the Extension Phase studies, subjects must have completed the Main Phase with FBG 150 mg/dL
The difficulty of GLP-1 receptor agonist oral products is that GLP-1 is easily degraded by enzymes in the gastrointestinal tract
The hard part isn't losing weight it's keeping it
US$ 21.87
US$ 25.76
US$ 26.24
US$ 25.52
